Company description

We are Ardena, a reputable contract partner delivering drug development, manufacturing, logistics and (bio)analytical services to pharmaceutical customers globally.  In parallel, we work with you to compile your regulatory dossier and to fast track your product towards compliance.  Every day, we guide companies through the hurdles and challenges of drug development.  Our integrated service offering helps to streamline the drug's progress to clinic and beyond. Ardena is your one source contractor for the chemical and pharmaceutical development of your valued compounds.  In parallel, we provide you with full product analytical and bioanalytical support during development.  Our dossier centric approach makes a difference.  We work with you to compile your regulatory dossier in parallel with drug development, saving you time, identifying hurdles and fast tracking your product to compliance.  We are experts in writing and formatting supporting CMC documentation.

Quick facts

Sales markets Western Europe; Eastern Europe; Middle East; Asia; North America
Affiliated categories: API Contract Manufacturing |Formulation development |Finished Dosage Forms More

Upcoming events

13 oct 2020

CPhI Worldwide 2020

13 - 15 October 2020 Milan, Italy Visit us at stand 2A20 Book a meeting See our Exhibitor Profile   See full Exhibitor List

Recently at

5 nov 2019

CPhI Worldwide 2019

5-7 November 2019 Frankfurt, Germany We were at stand 121H33 See our Exhibitor Profile   See full Exhibitor List

News about Ardena

GHO Capital acquires Ardena

14 Jan 2020

GHO Capital acquires Ardena

GHO Capital acquires Ardena, a leading CDMO providing early stage drug development and manufacturing for small-to-mid sized biopharma

Read more

24 Oct 2019

EMA request for Nitrosamine Risk Assessment

The European Medicines Agency (EMA) requests Marketing Authorization Holders to perform a Risk Assessment for the presence of Nitrosamines in all Chemically Synthesized API’s.

Read more

2 Sep 2019

Ardena launches Life Science Ingredients Arm

Contract development and manufacturing organization (CDMO) Ardena has launched Ardena LSI, a new arm of its business dedicated to the sale of chemical ingredients and intermediates for the life science industry.

Read more

22 Aug 2019

Ardena launches bimonthly newsletter

We are excited to launch our bimonthly newsletter, which is specifically designed to help biotech and pharma companies succeed in their drug development endeavors.

Read more